Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 1996

View Archived Issues

Therapeutically active cysteine proteinase inhibitors described by Synphar

Roussel Uclaf reports new quinoline derivatives

NK1 antagonists described by Boehringer Ingelheim

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Abbott reports on new PAF antagonists

Chugai reports new cholesterol-lowering compounds

New immunostimulant from Snow Brand

Antihypertensive peptides disclosed by Snow Brand

Novel mechanism of action reported for Xenova PAI inhibitor

Myriad Genetics announces research collaboration

Encouraging clinical results with MacroChem Rx for impotence

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Atlantic Pharmaceuticals issued U.S. patent

Positive phase IIa results for therapeutic vaccine for genital warts

PLC Systems allowed to expand Heart Laser trials

ADAC's Molecular Coincidence Detection shows promising results

Visible Genetics acquires BIOS Laboratories technology

RSV MAb from MedImmune enters pivotal trials

Biomira strengthens patent rights to Mucin 1 cancer antigen

5-LO inhibitor approved by FDA

NDA filed for Antizol

Taxotere now approved in 44 countries

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

BioProCon to market DiagnoCure bladder cancer diagnostic

New HIV-1 protease inhibitor in development at LG Chemical

New ET antagonist in preclinical testing at Parke-Davis

Vertex selects lead development candidate for autoimmune diseases

Ivax generic cardiovascular drug approved in U.S.

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Faulding receives approval for generic contrast media

DuPont Merck evaluates new candidate cognition enhancer

Oral butyrate prodrug in preclinical testing at Vertex

Advisory committee recommends approval of non-nicotine smoking cessation product

First marketing approval for Allergan antipsoriatic

BMS in-licenses antifungal triazole from Eisai

FDA panel recommends approval of BeneFix

Nortran's antiarrhythmic agents receive patent protection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...